Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry.
This paper examines the nature of Japanese government regulation of pharmaceutical prices, and the impact of that regulation on the competitive performance of the Japanese industry. Possible implications for the reintroduction of pharmaceutical price controls in the US are also considered.
Thomas
L G
LG
School of Business, Emory University, Atlanta, Georgia, USA.
D003363:Cost Control; D016527:Drug Costs / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence*; D004465:Economic Competition; D007564:Japan; D014481:United States